AMBRISENTAN (AMBRISENTAN) — FDA Approval ANDA210715 (CIPLA)
AMBRISENTAN (AMBRISENTAN) — FDA Approval ANDA210715 (CIPLA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: AMBRISENTAN; Active ingredients: AMBRISENTAN; Application number: ANDA210715.
| Brand name | AMBRISENTAN |
|---|---|
| Active ingredients | AMBRISENTAN |
| Application number | ANDA210715 |
| Sponsor | CIPLA |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20190426 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →